Cargando…
Impact of limb amputation and cisplatin chemotherapy on metastatic progression in mouse models of osteosarcoma
Development of animal models that accurately recapitulate human cancer is an ongoing challenge. This is particularly relevant in the study of osteosarcoma (OS), a highly malignant bone tumor diagnosed in approximately 1000 pediatric/adolescent patients each year. Metastasis is the leading cause of p...
Autores principales: | Ren, L., Huang, S., Beck, J., LeBlanc, Amy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709858/ https://www.ncbi.nlm.nih.gov/pubmed/34952927 http://dx.doi.org/10.1038/s41598-021-04018-9 |
Ejemplares similares
-
Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
por: Ren, L., et al.
Publicado: (2020) -
Osteosarcoma: A journey from amputation to limb salvage
por: Dhammi, Ish Kumar, et al.
Publicado: (2014) -
Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model
por: Robl, Bernhard, et al.
Publicado: (2016) -
A comparative study between limb-salvage and amputation for treating osteosarcoma
por: Li, Xiaojuan, et al.
Publicado: (2016) -
A meta‐analysis comparing efficiency of limb‐salvage surgery vs amputation on patients with osteosarcoma treated with neoadjuvant chemotherapy
por: Abdelgawad, Mohamed A, et al.
Publicado: (2022)